lunes, 27 de octubre de 2025

CAR-T therapies from Cabaletta, Bristol Myers Squibb induce remissions in patients with autoimmune disorders Small trials post encouraging data in severe inflammatory muscle disease

https://www.statnews.com/2025/10/27/cabaletta-bristol-myers-cart-autoimmune/

No hay comentarios:

Publicar un comentario